53/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0. Gray context columns never affect the score. CEO quarterly pay is the explicitly marked annual ÷ 4 estimate.
Trailing 1 year (4 quarters): 7 wins, 5 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly. Unavailable evidence scores 0 only in Win/Lose columns; gray columns award no points.
| Quarter | Total return | Revenue growth | EPS growth | Net marginNon-scoring | Trailing P/ENon-scoring | Price/bookNon-scoring | CEO quarterly payNon-scoring | Implied DilutionNon-scoring | Implied BuybackNon-scoring |
|---|---|---|---|---|---|---|---|---|---|
| 2026-Q23/3 |
WinGEN / S&P 32.89% / 15.20% |
WinGEN / S&P 20.16% / 15.00% |
WinGEN / S&P 76.29% / 50.40% |
Non-scoringGEN / S&P 20.73% / 15.70% | Non-scoringGEN / S&P 15.17 / 28.47 | Non-scoringGEN / S&P 6.01 / S&P unavailable | Non-scoringGEN / S&P GEN unavailable / S&P unavailable | Non-scoringGEN / S&P GEN unavailable / $0.00b | Non-scoringGEN / S&P GEN unavailable / $0.36b |
| 2026-Q12/3 |
LoseGEN / S&P -30.38% / -4.33% |
WinGEN / S&P 27.06% / 11.30% |
WinGEN / S&P 50.96% / 27.70% |
Non-scoringGEN / S&P 19.46% / 14.80% | Non-scoringGEN / S&P 11.61 / 25.43 | Non-scoringGEN / S&P 4.33 / S&P unavailable | Non-scoringGEN / S&P GEN unavailable / S&P unavailable | Non-scoringGEN / S&P GEN unavailable / $0.27b | Non-scoringGEN / S&P GEN unavailable / $0.00b |
| 2025-Q41/3 |
LoseGEN / S&P -3.78% / 2.65% |
WinGEN / S&P 21.55% / 9.00% |
LoseGEN / S&P -4.90% / 13.40% |
Non-scoringGEN / S&P 12.76% / 13.20% | Non-scoringGEN / S&P 26.20 / 28.48 | Non-scoringGEN / S&P 6.77 / 5.39 | Non-scoringGEN / S&P GEN unavailable / $4.42m | Non-scoringGEN / S&P GEN unavailable / $0.00b | Non-scoringGEN / S&P GEN unavailable / $0.20b |
| 2025-Q31/3 |
LoseGEN / S&P -3.05% / 8.12% |
WinGEN / S&P 16.15% / 4.61% |
LoseGEN / S&P -6.12% / 13.45% |
Non-scoringGEN / S&P 12.74% / 11.78% | Non-scoringGEN / S&P 30.11 / 28.13 | Non-scoringGEN / S&P 6.99 / 5.27 | Non-scoringGEN / S&P GEN unavailable / $4.42m | Non-scoringGEN / S&P GEN unavailable / $0.11b | Non-scoringGEN / S&P GEN unavailable / $0.00b |
| 2025-Q22/3 |
WinGEN / S&P 11.26% / 10.94% |
WinGEN / S&P 10.60% / 4.83% |
LoseGEN / S&P 2.11% / 10.63% |
Non-scoringGEN / S&P 14.12% / 11.45% | Non-scoringGEN / S&P 31.46 / 27.10 | Non-scoringGEN / S&P 7.94 / 5.01 | Non-scoringGEN / S&P GEN unavailable / $4.42m | Non-scoringGEN / S&P GEN unavailable / $0.00b | Non-scoringGEN / S&P GEN unavailable / $0.23b |
| 2025-Q11/3 |
WinGEN / S&P -2.63% / -4.27% |
LoseGEN / S&P 3.55% / 4.98% |
LoseGEN / S&P 9.47% / 10.57% |
Non-scoringGEN / S&P 16.34% / 11.39% | Non-scoringGEN / S&P 25.36 / 26.23 | Non-scoringGEN / S&P 7.19 / 4.69 | Non-scoringGEN / S&P GEN unavailable / $4.42m | Non-scoringGEN / S&P GEN unavailable / $0.00b | Non-scoringGEN / S&P GEN unavailable / $0.10b |
| 2024-Q40/3 |
LoseGEN / S&P 0.24% / 2.41% |
LoseGEN / S&P 3.38% / 5.25% |
LoseGEN / S&P -53.21% / 6.15% |
Non-scoringGEN / S&P 16.25% / 11.29% | Non-scoringGEN / S&P 26.95 / 28.60 | Non-scoringGEN / S&P 7.92 / 4.99 | Non-scoringGEN / S&P GEN unavailable / $4.28m | Non-scoringGEN / S&P GEN unavailable / $0.00b | Non-scoringGEN / S&P GEN unavailable / $0.08b |
| 2024-Q31/3 |
WinGEN / S&P 10.35% / 5.89% |
LoseGEN / S&P 2.69% / 5.89% |
LoseGEN / S&P -55.66% / 6.11% |
Non-scoringGEN / S&P 15.97% / 10.87% | Non-scoringGEN / S&P 27.51 / 28.09 | Non-scoringGEN / S&P 8.07 / 4.94 | Non-scoringGEN / S&P GEN unavailable / $4.28m | Non-scoringGEN / S&P GEN unavailable / $0.00b | Non-scoringGEN / S&P GEN unavailable / $0.21b |
| 2024-Q22/3 |
WinGEN / S&P 12.07% / 4.28% |
WinGEN / S&P 7.57% / 5.38% |
LoseGEN / S&P -54.76% / 5.12% |
Non-scoringGEN / S&P 15.72% / 10.85% | Non-scoringGEN / S&P 25.56 / 27.64 | Non-scoringGEN / S&P 7.80 / 4.79 | Non-scoringGEN / S&P GEN unavailable / $4.28m | Non-scoringGEN / S&P GEN unavailable / $0.00b | Non-scoringGEN / S&P GEN unavailable / $0.36b |
| 2024-Q11/3 |
LoseGEN / S&P -1.26% / 10.56% |
WinGEN / S&P 14.56% / 5.71% |
LoseGEN / S&P -55.61% / 5.59% |
Non-scoringGEN / S&P 15.97% / 10.81% | Non-scoringGEN / S&P 22.99 / 27.02 | Non-scoringGEN / S&P 6.52 / 4.71 | Non-scoringGEN / S&P GEN unavailable / $4.28m | Non-scoringGEN / S&P GEN unavailable / $0.00b | Non-scoringGEN / S&P GEN unavailable / $0.12b |
| 2023-Q43/3 |
WinGEN / S&P 29.87% / 11.69% |
WinGEN / S&P 21.08% / 6.81% |
WinGEN / S&P 142.22% / 7.78% |
Non-scoringGEN / S&P 36.58% / 11.19% | Non-scoringGEN / S&P 10.56 / 24.35 | Non-scoringGEN / S&P 6.15 / 4.31 | Non-scoringGEN / S&P GEN unavailable / $4.08m | Non-scoringGEN / S&P GEN unavailable / $0.00b | Non-scoringGEN / S&P GEN unavailable / $0.01b |
| 2023-Q32/3 |
LoseGEN / S&P -4.10% / -3.27% |
WinGEN / S&P 30.53% / 7.52% |
WinGEN / S&P 123.23% / -5.03% |
Non-scoringGEN / S&P 37.31% / 10.84% | Non-scoringGEN / S&P 8.10 / 23.93 | Non-scoringGEN / S&P 4.80 / 3.98 | Non-scoringGEN / S&P GEN unavailable / $4.08m | Non-scoringGEN / S&P GEN unavailable / $0.00b | Non-scoringGEN / S&P GEN unavailable / $0.24b |
| 2023-Q23/3 |
WinGEN / S&P 8.95% / 8.74% |
WinGEN / S&P 26.13% / 9.50% |
WinGEN / S&P 46.85% / -8.57% |
Non-scoringGEN / S&P 37.18% / 10.88% | Non-scoringGEN / S&P 8.97 / 24.01 | Non-scoringGEN / S&P 5.18 / 4.19 | Non-scoringGEN / S&P GEN unavailable / $4.08m | Non-scoringGEN / S&P GEN unavailable / $0.00b | Non-scoringGEN / S&P GEN unavailable / $0.17b |
| 2023-Q12/3 |
LoseGEN / S&P -19.46% / 7.50% |
WinGEN / S&P 18.63% / 10.77% |
WinGEN / S&P 51.77% / -15.69% |
Non-scoringGEN / S&P 40.22% / 10.82% | Non-scoringGEN / S&P 8.23 / 22.66 | Non-scoringGEN / S&P 5.10 / 3.93 | Non-scoringGEN / S&P GEN unavailable / $4.08m | Non-scoringGEN / S&P GEN unavailable / $0.00b | Non-scoringGEN / S&P GEN unavailable / $0.13b |
| 2022-Q41/3 |
LoseGEN / S&P 7.00% / 7.56% |
WinGEN / S&P 12.90% / 11.88% |
LoseGEN / S&P -41.18% / -17.99% |
Non-scoringGEN / S&P 17.83% / 11.09% | Non-scoringGEN / S&P 24.72 / 22.65 | Non-scoringGEN / S&P 10.45 / 3.75 | Non-scoringGEN / S&P GEN unavailable / $3.70m | Non-scoringGEN / S&P GEN unavailable / $0.00b | Non-scoringGEN / S&P GEN unavailable / $0.15b |
| 2022-Q30/3 |
LoseGEN / S&P -7.80% / -4.88% |
LoseGEN / S&P 6.84% / 13.47% |
LoseGEN / S&P -33.56% / -1.41% |
Non-scoringGEN / S&P 20.57% / 12.28% | Non-scoringGEN / S&P 22.53 / 20.58 | Non-scoringGEN / S&P 7.84 / 3.60 | Non-scoringGEN / S&P GEN unavailable / $3.70m | Non-scoringGEN / S&P GEN unavailable / $0.00b | Non-scoringGEN / S&P GEN unavailable / $0.17b |
| 2022-Q21/3 |
LoseGEN / S&P -16.77% / -16.10% |
LoseGEN / S&P 7.40% / 13.71% |
WinGEN / S&P 37.50% / 11.04% |
Non-scoringGEN / S&P 30.35% / 13.03% | Non-scoringGEN / S&P 14.88 / 20.28 | Non-scoringGEN / S&P GEN unavailable / 3.78 | Non-scoringGEN / S&P GEN unavailable / $3.70m | Non-scoringGEN / S&P GEN unavailable / $0.00b | Non-scoringGEN / S&P GEN unavailable / $0.17b |
| 2022-Q12/3 |
WinGEN / S&P 2.53% / -4.60% |
LoseGEN / S&P 9.60% / 15.97% |
WinGEN / S&P 53.26% / 42.23% |
Non-scoringGEN / S&P 29.90% / 14.22% | Non-scoringGEN / S&P 18.75 / 22.19 | Non-scoringGEN / S&P GEN unavailable / 4.51 | Non-scoringGEN / S&P GEN unavailable / $3.70m | Non-scoringGEN / S&P GEN unavailable / $0.00b | Non-scoringGEN / S&P GEN unavailable / $0.20b |
| 2021-Q40/3 |
LoseGEN / S&P 3.21% / 11.03% |
LoseGEN / S&P 10.39% / 15.00% |
LoseGEN / S&P 57.73% / 96.40% |
Non-scoringGEN / S&P 33.07% / 15.13% | Non-scoringGEN / S&P 16.62 / 23.63 | Non-scoringGEN / S&P GEN unavailable / 4.73 | Non-scoringGEN / S&P GEN unavailable / $3.63m | Non-scoringGEN / S&P GEN unavailable / $0.00b | Non-scoringGEN / S&P GEN unavailable / $0.13b |
| 2021-Q30/3 |
LoseGEN / S&P -6.60% / 0.58% |
LoseGEN / S&P 8.78% / 10.77% |
LoseGEN / S&P -70.61% / 69.42% |
Non-scoringGEN / S&P 32.95% / 14.13% | Non-scoringGEN / S&P 16.79 / 25.35 | Non-scoringGEN / S&P GEN unavailable / 4.38 | Non-scoringGEN / S&P GEN unavailable / $3.63m | Non-scoringGEN / S&P GEN unavailable / $0.00b | Non-scoringGEN / S&P GEN unavailable / $0.19b |
| 2021-Q22/3 |
WinGEN / S&P 28.60% / 8.55% |
WinGEN / S&P 6.89% / 6.58% |
LoseGEN / S&P -83.17% / 51.81% |
Non-scoringGEN / S&P 23.52% / 13.34% | Non-scoringGEN / S&P 25.61 / 26.70 | Non-scoringGEN / S&P GEN unavailable / 4.43 | Non-scoringGEN / S&P GEN unavailable / $3.63m | Non-scoringGEN / S&P GEN unavailable / $0.00b | Non-scoringGEN / S&P GEN unavailable / $0.11b |
| 2021-Q11/3 |
LoseGEN / S&P 2.93% / 6.17% |
WinGEN / S&P 2.45% / -1.06% |
LoseGEN / S&P -84.74% / 7.39% |
Non-scoringGEN / S&P 21.72% / 11.60% | Non-scoringGEN / S&P 22.43 / 30.50 | Non-scoringGEN / S&P GEN unavailable / 4.23 | Non-scoringGEN / S&P GEN unavailable / $3.63m | Non-scoringGEN / S&P GEN unavailable / $0.00b | Non-scoringGEN / S&P GEN unavailable / $0.10b |
| 2020-Q41/3 |
LoseGEN / S&P 0.38% / 12.15% |
WinGEN / S&P 0.00% / -3.72% |
LoseGEN / S&P -83.01% / -33.42% |
Non-scoringGEN / S&P 23.71% / 8.86% | Non-scoringGEN / S&P 20.64 / 39.26 | Non-scoringGEN / S&P GEN unavailable / 4.05 | Non-scoringGEN / S&P GEN unavailable / $3.17m | Non-scoringGEN / S&P GEN unavailable / $0.00b | Non-scoringGEN / S&P GEN unavailable / $0.01b |
| 2020-Q32/3 |
LoseGEN / S&P 5.68% / 8.93% |
WinGEN / S&P -0.72% / -2.04% |
WinGEN / S&P 259.57% / -27.10% |
Non-scoringGEN / S&P 131.80% / 9.24% | Non-scoringGEN / S&P 3.74 / 34.27 | Non-scoringGEN / S&P GEN unavailable / 3.65 | Non-scoringGEN / S&P GEN unavailable / $3.17m | Non-scoringGEN / S&P GEN unavailable / $0.02b | Non-scoringGEN / S&P GEN unavailable / $0.00b |
| 2020-Q21/3 |
LoseGEN / S&P 6.59% / 20.54% |
LoseGEN / S&P -1.60% / -0.46% |
WinGEN / S&P 3333.33% / -27.11% |
Non-scoringGEN / S&P 162.14% / 9.37% | Non-scoringGEN / S&P 2.97 / 31.29 | Non-scoringGEN / S&P GEN unavailable / 3.44 | Non-scoringGEN / S&P GEN unavailable / $3.17m | Non-scoringGEN / S&P GEN unavailable / $0.00b | Non-scoringGEN / S&P GEN unavailable / $0.03b |
| 2020-Q12/3 |
WinGEN / S&P 27.66% / -19.60% |
LoseGEN / S&P -17.00% / 3.47% |
WinGEN / S&P 14975.00% / -14.75% |
Non-scoringGEN / S&P 156.10% / 10.68% | Non-scoringGEN / S&P 2.77 / 22.80 | Non-scoringGEN / S&P 1077.28 / 2.92 | Non-scoringGEN / S&P GEN unavailable / $3.17m | Non-scoringGEN / S&P GEN unavailable / $0.00b | Non-scoringGEN / S&P GEN unavailable / $0.05b |
| 2019-Q41/3 |
LoseGEN / S&P 8.55% / 9.07% |
WinGEN / S&P 89.15% / 5.36% |
LoseGEN / S&P -5290.91% / 2.99% |
Non-scoringGEN / S&P 148.01% / 12.81% | Non-scoringGEN / S&P 4.30 / 22.78 | Non-scoringGEN / S&P 1.83 / 3.53 | Non-scoringGEN / S&P GEN unavailable / $3.08m | Non-scoringGEN / S&P GEN unavailable / $0.00b | Non-scoringGEN / S&P GEN unavailable / $0.05b |
| 2019-Q32/3 |
WinGEN / S&P 8.94% / 1.70% |
WinGEN / S&P 30.23% / 5.02% |
LoseGEN / S&P -21.67% / 0.21% |
Non-scoringGEN / S&P 36.55% / 12.41% | Non-scoringGEN / S&P 16.07 / 22.44 | Non-scoringGEN / S&P 2.39 / 3.30 | Non-scoringGEN / S&P GEN unavailable / $3.08m | Non-scoringGEN / S&P GEN unavailable / $0.00b | Non-scoringGEN / S&P GEN unavailable / $0.09b |
| 2019-Q20/3 |
LoseGEN / S&P -4.97% / 4.30% |
LoseGEN / S&P -1.81% / 6.64% |
LoseGEN / S&P GEN unavailable / 8.65% |
Non-scoringGEN / S&P 4.69% / 12.79% | Non-scoringGEN / S&P 131.84 / 21.37 | Non-scoringGEN / S&P 2.94 / 3.32 | Non-scoringGEN / S&P GEN unavailable / $3.08m | Non-scoringGEN / S&P GEN unavailable / $0.00b | Non-scoringGEN / S&P GEN unavailable / $0.27b |
| 2019-Q12/3 |
WinGEN / S&P 22.04% / 13.65% |
WinGEN / S&P 17.23% / 8.12% |
LoseGEN / S&P GEN unavailable / 14.29% |
Non-scoringGEN / S&P 1.03% / 12.97% | Non-scoringGEN / S&P 467.22 / 20.86 | Non-scoringGEN / S&P 2.52 / 3.26 | Non-scoringGEN / S&P GEN unavailable / $3.08m | Non-scoringGEN / S&P GEN unavailable / $0.00b | Non-scoringGEN / S&P GEN unavailable / $34.35b |
| 2018-Q41/3 |
WinGEN / S&P -10.90% / -13.52% |
LoseGEN / S&P -72.19% / 9.05% |
LoseGEN / S&P GEN unavailable / 18.23% |
Non-scoringGEN / S&P -4.70% / 13.10% | Non-scoringGEN / S&P GEN unavailable / 19.39 | Non-scoringGEN / S&P 2.01 / 2.94 | Non-scoringGEN / S&P GEN unavailable / $3.00m | Non-scoringGEN / S&P GEN unavailable / $0.01b | Non-scoringGEN / S&P GEN unavailable / $0.00b |
| 2018-Q30/3 |
LoseGEN / S&P 3.45% / 7.71% |
LoseGEN / S&P -58.17% / 10.21% |
LoseGEN / S&P GEN unavailable / 19.06% |
Non-scoringGEN / S&P 63.55% / 13.01% | Non-scoringGEN / S&P 11.07 / 22.25 | Non-scoringGEN / S&P 2.26 / 3.45 | Non-scoringGEN / S&P GEN unavailable / $3.00m | Non-scoringGEN / S&P GEN unavailable / $0.00b | Non-scoringGEN / S&P GEN unavailable / $0.17b |
| 2018-Q20/3 |
LoseGEN / S&P -19.84% / 3.43% |
LoseGEN / S&P -41.07% / 9.03% |
LoseGEN / S&P GEN unavailable / 14.46% |
Non-scoringGEN / S&P 47.68% / 12.56% | Non-scoringGEN / S&P 10.76 / 22.49 | Non-scoringGEN / S&P 2.20 / 3.25 | Non-scoringGEN / S&P GEN unavailable / $3.00m | Non-scoringGEN / S&P GEN unavailable / $0.00b | Non-scoringGEN / S&P GEN unavailable / $0.19b |
| 2018-Q10/3 |
LoseGEN / S&P -7.62% / -0.76% |
LoseGEN / S&P -36.33% / 7.68% |
LoseGEN / S&P GEN unavailable / 12.46% |
Non-scoringGEN / S&P 44.47% / 12.27% | Non-scoringGEN / S&P 14.17 / 23.41 | Non-scoringGEN / S&P 3.21 / 3.17 | Non-scoringGEN / S&P GEN unavailable / $3.00m | Non-scoringGEN / S&P GEN unavailable / $0.00b | Non-scoringGEN / S&P GEN unavailable / $0.08b |
| 2017-Q41/3 |
LoseGEN / S&P -14.25% / 6.64% |
WinGEN / S&P 25.47% / 7.03% |
LoseGEN / S&P GEN unavailable / 13.82% |
Non-scoringGEN / S&P 22.24% / 12.09% | Non-scoringGEN / S&P 16.54 / 24.25 | Non-scoringGEN / S&P 3.52 / 3.23 | Non-scoringGEN / S&P GEN unavailable / $2.92m | Non-scoringGEN / S&P GEN unavailable / $0.00b | Non-scoringGEN / S&P GEN unavailable / $0.05b |
| 2017-Q32/3 |
WinGEN / S&P 16.45% / 4.48% |
WinGEN / S&P 25.40% / 5.68% |
LoseGEN / S&P GEN unavailable / 17.57% |
Non-scoringGEN / S&P -5.29% / 12.04% | Non-scoringGEN / S&P GEN unavailable / 23.28 | Non-scoringGEN / S&P 0.01 / 3.08 | Non-scoringGEN / S&P GEN unavailable / $2.92m | Non-scoringGEN / S&P GEN unavailable / $0.00b | Non-scoringGEN / S&P GEN unavailable / $0.11b |
| 2017-Q21/3 |
LoseGEN / S&P -7.69% / 3.09% |
WinGEN / S&P 20.66% / 4.83% |
LoseGEN / S&P -116.22% / 17.74% |
Non-scoringGEN / S&P -8.68% / 11.96% | Non-scoringGEN / S&P GEN unavailable / 23.40 | Non-scoringGEN / S&P 5.09 / 3.03 | Non-scoringGEN / S&P GEN unavailable / $2.92m | Non-scoringGEN / S&P GEN unavailable / $0.00b | Non-scoringGEN / S&P GEN unavailable / $0.08b |
| 2017-Q12/3 |
WinGEN / S&P 28.76% / 6.07% |
WinGEN / S&P 11.64% / 3.67% |
LoseGEN / S&P -104.58% / 13.32% |
Non-scoringGEN / S&P -2.64% / 11.75% | Non-scoringGEN / S&P GEN unavailable / 23.60 | Non-scoringGEN / S&P 5.35 / 3.01 | Non-scoringGEN / S&P GEN unavailable / $2.92m | Non-scoringGEN / S&P GEN unavailable / $0.00b | Non-scoringGEN / S&P GEN unavailable / $20.24b |
| 2016-Q42/3 |
LoseGEN / S&P -4.52% / 3.82% |
WinGEN / S&P 4.16% / 2.09% |
WinGEN / S&P 246.67% / 7.05% |
Non-scoringGEN / S&P 55.12% / 11.37% | Non-scoringGEN / S&P 7.10 / 23.76 | Non-scoringGEN / S&P 3.74 / 2.91 | Non-scoringGEN / S&P GEN unavailable / $2.88m | Non-scoringGEN / S&P GEN unavailable / $0.00b | Non-scoringGEN / S&P GEN unavailable / $1.11b |
| 2016-Q32/3 |
WinGEN / S&P 22.60% / 3.85% |
LoseGEN / S&P -1.14% / 0.20% |
WinGEN / S&P 240.21% / -3.15% |
Non-scoringGEN / S&P 60.52% / 10.82% | Non-scoringGEN / S&P 7.09 / 24.22 | Non-scoringGEN / S&P 4.05 / 2.78 | Non-scoringGEN / S&P GEN unavailable / $2.88m | Non-scoringGEN / S&P GEN unavailable / $0.00b | Non-scoringGEN / S&P GEN unavailable / $0.16b |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | GEN total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 3.01% | 20.78% |
| Annualized return | 3.01% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | GEN total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 26.51% | 83.14% |
| Annualized return | 4.82% | 12.86% |
10Y · 2016-09-01 to 2026-08-27
| Metric | GEN total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 163.19% | 319.30% |
| Annualized return | 10.16% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
- Net margin, P/E, P/B and other gray context columns never enter the score.
Snapshot captured 2026-09-04.